![Edward Kolb](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Edward Kolb
Chief Executive Officer at The Leukemia & Lymphoma Society, Inc.
Edward Kolb active positions
Companies | Position | Start | End |
---|---|---|---|
The Leukemia & Lymphoma Society, Inc.
![]() The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Chief Executive Officer | 30/04/2023 | - |
President | 30/04/2023 | - |
Career history of Edward Kolb
Training of Edward Kolb
Thomas Jefferson University | Doctorate Degree |
University of Pennsylvania | Undergraduate Degree |
Statistics
International
United States | 4 |
Operational
Chief Executive Officer | 1 |
President | 1 |
Doctorate Degree | 1 |
Sectoral
Consumer Services | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
The Leukemia & Lymphoma Society, Inc.
![]() The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Commercial Services |
- Stock Market
- Insiders
- Edward Kolb
- Experience